VALLEY CHILDRENS HOSPITAL
1. Target Overview & Investment Thesis
VALLEY CHILDRENS HOSPITAL is a 358-bed safety-net/medicaid heavy in MADERA, CA with $1.01B in net patient revenue and a 25.0% operating margin. The hospital serves a payer mix of 0.1% Medicare, 48.8% Medicaid, and 51.1% commercial.
Thesis: Platform Growth. Our ML models identify $74.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 25.0% to 32.4% (+736bps).
| Net Revenue HCRIS | $1.01B |
| Current EBITDA COMPUTED | $252.9M |
| Operating Margin COMPUTED | 25.0% |
| Occupancy HCRIS | 50.5% |
| Revenue / Bed COMPUTED | $2.8M |
| Net-to-Gross HCRIS | 49.3% |
| Distress Probability ML | 58.6% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 25.0% places it above the state median. Among 154 size-comparable peers (179-716 beds), the median margin is -4.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (179-716), prioritizing same-state peers. 154 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| VALLEY CHILDRENS HOSPITAL (Target) | CA | 358 | $1.01B | 25.0% |
| STANFORD HEALTH CARE | CA | 657 | $6.76B | 3.7% |
| UC DAVIS MEDICAL CENTER | CA | 666 | $3.28B | -11.5% |
| RONALD REAGAN UCLA | CA | 446 | $2.62B | -6.8% |
| LUCILE PACKARD CHILDRENS HOSPI | CA | 394 | $2.39B | -0.8% |
| LOS ANGELES GENERAL MEDICAL CE | CA | 596 | $1.96B | 10.2% |
| UCI MEDICAL CENTER | CA | 397 | $1.90B | -2.5% |
| CITY OF HOPE NATIONAL MEDICAL | CA | 217 | $1.83B | -10.7% |
| RADY CHILDRENS HOSPITAL - SAN | CA | 401 | $1.82B | 14.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $74.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $21.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $20.2M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $20.0M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $12.3M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $646K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $252.9M |
| + RCM Uplift | +$74.4M |
| Pro Forma EBITDA | $327.2M |
| Current Margin | 25.0% |
| Pro Forma Margin | 32.4% |
| WC Released (1x) | $38.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $389.1M | $2.41B | 6.20x | 44.0% |
| Base (11x exit) | 10.0x | 11.0x | $389.1M | $2.78B | 7.14x | 48.2% |
| Bull Case | 9.0x | 11.0x | $350.1M | $3.15B | 9.00x | 55.2% |
| Bull (12x exit) | 9.0x | 12.0x | $350.1M | $3.54B | 10.11x | 58.8% |
| Bear Case | 11.0x | 10.0x | $428.0M | $1.91B | 4.47x | 34.9% |
| Bear (11x exit) | 11.0x | 11.0x | $428.0M | $2.24B | 5.24x | 39.3% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Elevated Medicaid exposure (48.8%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 58.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 154 hospitals with 179-716 beds
- Same-state prioritization (n=155)
- Comp margins: P25=-15.9% / P50=-4.4% / P75=3.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.